IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 47 filers reported holding IKENA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,858,421 | -18.5% | 1,352,984 | +23.5% | 0.00% | – |
| Q2 2023 | $7,184,315 | +108.5% | 1,095,170 | +9.7% | 0.00% | – |
| Q1 2023 | $3,445,128 | +32.2% | 998,588 | +1.9% | 0.00% | – |
| Q4 2022 | $2,605,515 | -25.0% | 979,517 | +0.1% | 0.00% | – |
| Q3 2022 | $3,475,000 | +16.3% | 979,003 | +45.2% | 0.00% | – |
| Q2 2022 | $2,987,000 | -38.0% | 674,105 | -14.7% | 0.00% | – |
| Q1 2022 | $4,819,000 | -50.9% | 789,999 | +1.0% | 0.00% | – |
| Q4 2021 | $9,811,000 | +25.3% | 782,394 | +26.1% | 0.00% | – |
| Q3 2021 | $7,833,000 | +69.8% | 620,686 | +88.9% | 0.00% | – |
| Q2 2021 | $4,613,000 | +172.2% | 328,612 | +447.7% | 0.00% | – |
| Q1 2021 | $1,695,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |